SEC Form 4 · accession 0001181431-15-006736
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Raleigh Nunn
Director
Period of report
May 7, 2015
Accepted (ET)
May 11, 2015 · 2:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 7, 2015 | U | 70 | $46.00 | D | 0 | I | held by Jake and Dana Nunn Living Trust U/A DTD 07/07/06 |
| Common StockF2 | May 7, 2015 | D | 2,617 | $46.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $4.08 | May 7, 2015 | D | 11,855 | D | — | Apr 14, 2021 | Common Stock | 11,855 | 0 | D |
| Stock Option (Right to Buy)F3 | $7.31 | May 7, 2015 | D | 4,105 | D | — | Apr 15, 2022 | Common Stock | 4,105 | 0 | D |
| Stock Option (Right to Buy)F3 | $24.46 | May 7, 2015 | D | 9,800 | D | — | Apr 14, 2023 | Common Stock | 9,800 | 0 | D |
| Stock Option (Right to Buy)F3 | $26.97 | May 7, 2015 | D | 4,869 | D | — | May 26, 2024 | Common Stock | 4,869 | 0 | D |
Explanation of responses
- F1Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the Issuer.
- F2Restricted stock units covering shares of Issuer common stock that will be cashed-out and cancelled in connection with the merger of the Issuer and Horizon (the "Merger").
- F3Options to acquire shares of Issuer common stock that will be cashed-out and cancelled in connection with the Merger.